Publicaciones en colaboración con investigadores/as de University of Tampere (3)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2018

  1. HOXA9 cooperates with activated JAK/STAT signaling to drive leukemia development

    Cancer Discovery, Vol. 8, Núm. 5, pp. 616-631